Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34433650)

  • 1. Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care.
    Chakraborty S; Ecker BL; Seier K; Aveson VG; Balachandran VP; Drebin JA; D'Angelica MI; Kingham TP; Sigel CS; Soares KC; Vakiani E; Wei AC; Chandwani R; Gonen M; Shen R; Jarnagin WR
    Clin Cancer Res; 2021 Nov; 27(21):5891-5899. PubMed ID: 34433650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.
    Perkins G; Svrcek M; Bouchet-Doumenq C; Voron T; Colussi O; Debove C; Merabtene F; Dumont S; Sauvanet A; Hammel P; Cros J; André T; Bachet JB; Bardier A; Douard R; Meatchi T; Peschaud F; Emile JF; Cojean-Zelek I; Laurent-Puig P; Taieb J
    Br J Cancer; 2019 Apr; 120(7):697-702. PubMed ID: 30837681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
    Mikhitarian K; Pollen M; Zhao Z; Shyr Y; Merchant NB; Parikh A; Revetta F; Washington MK; Vnencak-Jones C; Shi C
    Mod Pathol; 2014 May; 27(5):665-74. PubMed ID: 24186143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
    Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
    Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.
    Reid MD; Balci S; Ohike N; Xue Y; Kim GE; Tajiri T; Memis B; Coban I; Dolgun A; Krasinskas AM; Basturk O; Kooby DA; Sarmiento JM; Maithel SK; El-Rayes BF; Adsay V
    Mod Pathol; 2016 Dec; 29(12):1575-1585. PubMed ID: 27586202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
    Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
    BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
    Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
    Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
    Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
    J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
    Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
    Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.
    Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S
    J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
    Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
    Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma.
    Cheng J; Mao Y; Hong W; Hu W; Shu P; Huang K; Yu J; Jiang M; Li L; Wang W; Ni D; Li S
    J Transl Med; 2022 Jun; 20(1):272. PubMed ID: 35705951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets.
    Dong Z; Chong W; Chen C; Qi L; Mengke L; Minghui D; Jiawei Y; Longxi Q; Hengchao L; Liu J; Zhimin G
    BMC Cancer; 2024 Mar; 24(1):286. PubMed ID: 38439030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma.
    Sandhu V; Wedge DC; Bowitz Lothe IM; Labori KJ; Dentro SC; Buanes T; Skrede ML; Dalsgaard AM; Munthe E; Myklebost O; Lingjærde OC; Børresen-Dale AL; Ikdahl T; Van Loo P; Nord S; Kure EH
    Cancer Res; 2016 Sep; 76(17):5092-102. PubMed ID: 27488532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.